Wolfgang Kern Selected Research

Wolfgang Kern Research Topics

Disease

33	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2003
19	Neoplasms (Cancer) 05/2024 - 10/2003
17	Leukemia 01/2022 - 08/2003
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 06/2006
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 06/2004
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2003
5	Residual Neoplasm 01/2022 - 01/2008
5	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 06/2013
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019 - 04/2005
4	Acute Promyelocytic Leukemia 12/2011 - 01/2002
3	Lymphoma (Lymphomas) 01/2022 - 10/2016
3	Eosinophilia 01/2018 - 06/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 12/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 07/2010
2	Neutropenia 02/2020 - 04/2009
2	Multiple Myeloma 01/2020 - 07/2010
2	Refractory Anemia 05/2013 - 06/2007
1	Thalassemia 03/2024
1	VEXAS syndrome 01/2023
1	Cytopenia 01/2023
1	Inflammation (Inflammations) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2022
1	Carcinogenesis 01/2022
1	Infections 02/2020
1	Thrombocytosis (Thrombocythemia) 05/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2012
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2011
1	Glioma (Gliomas) 12/2010
1	Systemic Mastocytosis 11/2010
1	Primary Myelofibrosis (Myelosclerosis) 11/2010
1	Philadelphia Chromosome 10/2010
1	Refractory Anemia with Excess of Blasts (RAEM) 06/2007
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2007

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2003
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2011
4	OligonucleotidesIBA 07/2010 - 08/2003
4	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2009 - 12/2003
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2006
3	Phosphotransferases (Kinase)IBA 01/2022 - 10/2010
3	RNA Splicing FactorsIBA 01/2021 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2005
3	Differentiation AntigensIBA 01/2017 - 09/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2013 - 01/2008
3	AntigensIBA 05/2013 - 11/2006
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2018
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2018 - 06/2013
2	NucleophosminIBA 09/2009 - 12/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2006 - 06/2006
2	Proteins (Proteins, Gene)FDA Link 11/2006 - 09/2003
2	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2006 - 12/2003
2	Codon (Codons)IBA 05/2006 - 03/2006
2	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 04/2005 - 01/2002
2	Monoclonal AntibodiesIBA 11/2004 - 01/2004
1	OMS 2017IBA 03/2024
1	GlobinsIBA 03/2024
1	Initiator Codon (Start Codon)IBA 01/2023
1	PolymersIBA 09/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	AICDA (activation-induced cytidine deaminase)IBA 12/2021
1	Genetic Markers (Genetic Marker)IBA 08/2021
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	BI 6727IBA 02/2020
1	ChromatinIBA 01/2020
1	Complementary DNA (cDNA)IBA 10/2019
1	venetoclaxIBA 04/2018
1	Lenalidomide (CC 5013)FDA Link 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Cyclin D1IBA 12/2013
1	Janus Kinase 2IBA 06/2013
1	MDS1 and EVI1 Complex Locus ProteinIBA 12/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 05/2012
1	CD8 AntigensIBA 05/2012
1	Core Binding Factor Alpha 2 SubunitIBA 12/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2011
1	Cyclin-Dependent Kinase Inhibitor p27IBA 06/2011
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2010
1	EnzymesIBA 12/2010
1	Tryptases (Tryptase)IBA 11/2010
1	Imatinib Mesylate (Gleevec)FDA Link 10/2010
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 07/2010
1	Core Binding Factors (Core-Binding Factor)IBA 07/2010
1	MDS 11IBA 10/2009
1	pegfilgrastim (Neulasta)FDA Link 04/2009
1	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2007
1	Interleukin-2 (IL2)IBA 11/2006
1	CPG-oligonucleotideIBA 11/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2006

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2003
5	Drug Therapy (Chemotherapy) 01/2022 - 06/2004
3	Induction Chemotherapy 11/2018 - 07/2006
3	Stem Cell Transplantation 01/2017 - 06/2006
2	Hematopoietic Stem Cell Transplantation 05/2024 - 12/2010
2	Remission Induction 01/2022 - 01/2003
2	Time-to-Treatment 10/2010 - 09/2010
1	Immunotherapy 05/2024
1	Aftercare (After-Treatment) 01/2020